FDA to make a decision on whether to approve first Alzheimer’s drug
The FDA is set to decide whether it will fully approve the first Alzheimer’s drug to show it could slow the disease’s progression in certain patients. But the decision could also have other implications, including who would get access to it. The FDA is set to decide whether it willContinue Reading
